Valuation: AroCell AB

Market Cap 86.62M 8.74M 7.67M 7.21M 6.59M 12.32M 837M 12.41M 33.58M 427M 32.82M 32.1M 1.38B P/E 2024
-2.12x
P/E 2025 -6.69x
Enterprise Value 63.28M 6.39M 5.6M 5.27M 4.82M 9M 612M 9.07M 24.53M 312M 23.98M 23.45M 1.01B EV / Sales 2024
0.73x
EV / Sales 2025 1.09x
Free-Float
68.85%
Yield 2024 *
-
Yield 2025 -
1 day-3.34%
1 week-6.00%
Current month-4.57%
1 month-8.52%
3 months-11.74%
6 months+18.24%
Current year+6.52%
1 week 0.37
Extreme 0.373
0.4
1 month 0.37
Extreme 0.373
0.45
Current year 0.25
Extreme 0.25
0.53
1 year 0.25
Extreme 0.25
0.53
3 years 0.25
Extreme 0.25
0.66
5 years 0.25
Extreme 0.25
2.4
10 years 0.25
Extreme 0.25
8.45
Manager TitleAgeSince
Chief Executive Officer - 27/05/2026
Director of Finance/CFO - 17/08/2022
Chief Tech/Sci/R&D Officer - 31/12/2024
Director TitleAgeSince
Director/Board Member 56 31/12/2019
Chairman 39 21/05/2024
Director/Board Member 74 31/12/2022
Date Insider Type Main position Quantity % Market Cap. Importance
02/09/21 Buy

Executive/Senior Manager

25,000 0.0220%
02/09/21 Buy 20,000 0.0176%
01/09/21 Buy

Director

5,353 0.0047%
Change 5-day change 1-year change 3-year change Capi.($)
-3.34%-6.00%-5.29%-26.56% 9.09M
-0.18%+4.35%+4.23%+31.79% 47.86B
-0.83%-0.36%+43.66%+34.77% 44.46B
-0.84%+4.86%+10.92%+91.52% 41.85B
-1.10%-2.64%+331.49%+535.80% 41.34B
-0.62%+0.11%+1.12%+46.02% 30.04B
-2.07%+0.12%+24.39%+154.30% 17.59B
-3.55%+1.95%+21.97%+38.83% 15.69B
-6.08%-9.92% - - 15.6B
-0.78%+9.46%-8.96% - 13.93B
Average -1.84%+1.76%+47.06%+113.31% 26.84B
Weighted average by Cap. -1.11%+1.33%+67.20%+141.32%

Financials

2024 2025
Net sales 57.44M 5.8M 5.09M 4.78M 4.37M 8.17M 555M 8.23M 22.27M 283M 21.77M 21.29M 918M 53.11M 5.36M 4.7M 4.42M 4.04M 7.55M 513M 7.61M 20.59M 262M 20.12M 19.68M 849M
Net income -42.45M -4.28M -3.76M -3.53M -3.23M -6.04M -410M -6.08M -16.46M -209M -16.09M -15.73M -678M -12.15M -1.23M -1.08M -1.01M -925K -1.73M -117M -1.74M -4.71M -59.88M -4.6M -4.5M -194M
Net Debt -47.78M -4.82M -4.23M -3.98M -3.64M -6.8M -462M -6.85M -18.52M -235M -18.11M -17.71M -764M -23.34M -2.36M -2.07M -1.94M -1.78M -3.32M -226M -3.34M -9.05M -115M -8.84M -8.65M -373M
Logo AroCell AB
IDL Diagnostics AB (publ), formerly AroCell AB (publ), is a Sweden-based diagnostic Company engaged in the biotechnology and medical diagnostics industry. The Company focuses on research, development, manufacturing, and commercialization of diagnostic and medical technology products. The Company has a broad product portfolio of In Vitro Diagnostics (IVD) tests that deliver clinical information for the detection of disease with indications spanning everything from urological cancers to typhoid fever. IDL Diagnostics AB (publ) develops tests that are clinically useful and economically viable. The Company provides rapid tests, laboratory tests and platform tests that improve decision making and are non-invasive, cost effective, as well as easy to perform.
Employees
25
Date Price Change Volume
23/09/26 SEK 0.3760 -3.34% 16,766
22/09/26 SEK 0.3890 +4.01% 171,026
21/09/26 SEK 0.3740 -5.32% 404,902
18/09/26 SEK 0.3950 +1.28% 145,475
17/09/26 SEK 0.3900 -2.50% 10,754

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IDLDX Stock